CF
RENEW

Cantor Fitzgerald’s Cartesian Growth Corporation II Warrant RENEW Stock Holding History

Cantor Fitzgerald’s Portfolio RENEW Stock Details RENEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,397,500
Closed -$264K – 504
2025
Q2 		$264K Hold
2,397,500
– – ﹤0.01% 282
2025
Q1 		$169K Buy
2,397,500
+1,897,500
+380% +$138K ﹤0.01% 224
2024
Q4 		$37.5K Hold
500,000
– – ﹤0.01% 229
2024
Q3 		$30K Sell
500,000
-1,897,500
-79% -$155K ﹤0.01% 171
2024
Q2 		$50.5K Hold
2,397,500
– – 0.01% 181
2024
Q1 		$70.2K Hold
2,397,500
– – 0.02% 175
2023
Q4 		$65K Buy
2,397,500
+1,897,500
+380% +$245K 0.01% 164
2023
Q3 		$80K Sell
500,000
-1,897,500
-79% -$317K ﹤0.01% 467
2023
Q2 		$78.5K Hold
2,397,500
– – ﹤0.01% 496
2023
Q1 		$80.1K Hold
2,397,500
– – ﹤0.01% 576
2022
Q4 		$112K Hold
2,397,500
– – ﹤0.01% 601
2022
Q3 		$69K Buy
+2,397,500
New +$403K ﹤0.01% 644

Other funds holding RENEW

MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Cantor Fitzgerald's RENEW Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Cartesian Growth Corporation II Warrant (RENEW) in Q3 2025, closing a stake of 2,397,500 shares — an estimated $264K sold.

Cantor Fitzgerald first reported a position in RENEW in Q3 2022 and held it in 12 quarters. The position peaked at $264K in Q2 2025. 1 fund tracked by Wall St. Rank holds RENEW as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Cartesian Growth Corporation II Warrant position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 2,397,500 Cartesian Growth Corporation II Warrant shares in Q3 2025, an estimated $264K.
  • Cantor Fitzgerald first reported a position in Cartesian Growth Corporation II Warrant in Q3 2022 and held it in 12 quarters.
  • Cantor Fitzgerald's Cartesian Growth Corporation II Warrant position peaked at $264K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Cartesian Growth Corporation II Warrant as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.